Synthetic Biologics Reports Year End 2014 Financial Results and Operational Highlights
— Steady Progress in All Programs; Two Phase 2 Clinical Trials to Start in 2015 — — Conference Call Today, March 16, 2015, at 8:30 a.m. (ET) — ROCKVILLE, Md., March 16, 2015 /PRNewswire/ — Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting […]
Synthetic Biologics Reports Year End 2014 Financial Results and Operational Highlights Read More »